Sionna Therapeutics Inc.
SION | NASDAQ
$6
+$0.04 (+0.67%)
At close: Sep 21, 2026, 4:00 PM ET
$5.88
-$0.12 (-2.00%)
Pre-market:
Sep 22, 2026, 8:01 AM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 |
|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a |
Cost of Revenue | 647K | 668K | n/a | n/a |
Gross Profit | -647K | -668K | n/a | n/a |
Operating Income | -88.98M | -70.56M | -50.33M | -41.37M |
Interest Income | 13.3M | 8.17M | 2.77M | 1.13M |
Pretax Income | -75.27M | -61.69M | -47.26M | -40.24M |
Net Income | -75.27M | -61.69M | -47.26M | -40.24M |
Selling & General & Admin | 28.72M | 13.27M | 9.71M | 6.77M |
Research & Development | 60.26M | 57.29M | 40.63M | 34.61M |
Other Expenses | -647K | -668K | n/a | n/a |
Operating Expenses | 88.34M | 69.89M | 50.33M | 41.37M |
Interest Expense | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a |
Cost & Expenses | 88.98M | 70.56M | 50.33M | 41.37M |
Income Tax Expense | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 39.96M | 44.12M | 44.12M | 44.12M |
Shares Outstanding (Diluted) | 39.96M | 44.12M | 44.12M | 44.12M |
EPS (Basic) | -1.88 | -1.40 | -1.07 | -0.91 |
EPS (Diluted) | -1.88 | -1.40 | -1.07 | -0.91 |
EBITDA | -74.62M | -61.02M | -46.68M | -40.12M |
EBIT | -75.27M | -61.69M | -47.26M | -40.24M |
Depreciation & Amortization | 647K | 668K | 583K | 122K |
Add to Watchlist
Select watchlists to add or remove SION